Research Article

Comparison of Serum Albumin Separation by Ammonium Sulfate Precipitation and Cibacron Blue Affinity Chromatography

Volume: 4 Number: 2 September 3, 2025

Comparison of Serum Albumin Separation by Ammonium Sulfate Precipitation and Cibacron Blue Affinity Chromatography

Abstract

Serum albumin, which is synthesized in the liver and has many physiological functions, is one of the most abundant proteins in plasma. Albumin is a valuable biomarker of many diseases and has indications in many diseases. The increasing use of albumin in biotechnological applications, its important ligand-carrying properties and its wide range of applications in clinical and basic scientific studies require high purity serum albumin separation. Many methods such as ammonium sulfate precipitation, heat shock method, plasma fractionation with ethanol, chromatographic methods (column, affinity), acetone/trichloroacetic acid precipitation are used for albumin separation from serum. In this study, 2 methods based on ammonium sulfate precipitation and Cibacron Blue affinity chromatography were compared. The purity of the isolated proteins was monitored by SDS-PAGE and densitometrically analyzed. The selected methods were evaluated in terms of time, applicability, purity and cost. İt was concluded that ammonium sulfate precipitation provided a more successful separation in terms of albumin yield and purity compared to Cibacron Blue affinity chromatography.

Keywords

: Serum Albumin , Ammonium Sulfate , Cibacron Blue F3GA , Affinity Chromatography , Protein Fractionation

References

  1. [1] Quinlan GJ, Martin GS, Evans TW. Albumin: Biochemical properties and therapeutic potential. Hepatology, 2005;41:1211–9.
  2. [2] Farrugia A. Albumin Usage in Clinical Medicine: Tradition or Therapeutic? Transfus Med Rev, 2010;24(1):53–63.
  3. [3] Raoufinia R, Mota A, Nozari S, Aghebati Maleki L, Balkani S, Abdolalizadeh J. A methodological approach for purification and characterization of human serum albumin. J Immunoassay Immunochem, 2016;37(6):601–14.
  4. [4] Peters TJ. Metabolism: Albumin in the body. In: All About Albumin. Biochemistry, Genetics, and Medical Application, San Diego: Academic Press. 1996.
  5. [5] Evans TW. Review article: Albumin as a drug - Biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther Suppl, 2002;16(Suppl 5):6–11.
  6. [6] Mendez CM, McClain CJ, Marsano LS. Albumin therapy in clinical practice. Nutr Clin Pract, 2005;20(3):314–20.
  7. [7] Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J, 2010;9:69.
  8. [8] Denizli A. Plasma fractionation: conventional and chromatographic methods for albumin purification. Hacettepe Journal of Biology and Chemistry, 2011;39(394):315–41.
  9. [9] Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocrine Journal, 2010;57(9):751–62.
  10. [10] Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - Review and clinical implications. Clinical Chemistry and Laboratory Medicine, 2011;49(2):177–84.
EndNote
Çiğ E, Güldür T (September 1, 2025) Comparison of Serum Albumin Separation by Ammonium Sulfate Precipitation and Cibacron Blue Affinity Chromatography. Anatolian Journal of Pharmaceutical Sciences 4 2 63–75.